December 2022 - Page 21 of 22

FridayDec 02, 2022 10:46 am

QualityStocksNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Commences Trial Evaluating IGC-AD1 for the Treatment of Alzheimer’s-Related Symptoms

India Globalization Capital (NYSE American: IGC) announced that it has begun “A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Trial of the Safety and Efficacy of IGC-AD1 on Agitation in Participants with Dementia due to Alzheimer’s Disease.” According to the announcement, the company has commenced the phase 2 study at two U.S. sites and plans to add between three to five additional sites in the United States, Canada and possibly South America. “We believe that IGC-AD1 has the potential to revolutionize the treatment of Alzheimer’s Disease as the first and only low-dose natural THC-based formulation candidate currently undergoing FDA trials,” said…

FridayDec 02, 2022 9:45 am

Vision Energy Corp. (VIHDD) Develops Carbon-Reduced Solutions for Commercial, Industrial, and Transportation Industries, as It Pursues Landmark Design for First European Terminal

The European Green Deal, with the objective to become climate-neutral by 2050, implies a near-total phase-out of fossil fuels in the EU energy system Vision Energy signed a cooperation agreement with Linde Engineering to accelerate efforts for its pioneering Green Energy Terminal in the North Sea Port of Vlissingen, the Netherlands Engineering efforts under the agreement have commenced and are anticipated to conclude in April 2023, supporting the company’s target to reach a Final Investment Decision by Q3 2023 Hydrogen presents a global opportunity to reduce greenhouse gas emissions due to its high efficiency and zero-or near-zero-emissions operation. The global…

FridayDec 02, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Moves Forward With Exploration of Patented DehydraTECH(TM)-Processed CBD for Dementia

Approximately 55 million people worldwide have dementia, which is expected to grow to 78 million by 2030 The dementia treatment market was valued at $13.78 billion in 2021. The market is expected to grow at a CAGR of 8.32%, resulting in a value of $26.13 billion by 2029 Clinical studies have established a connection between hypertension and dementia With DehydraTECH(TM)-CBD already evidencing that it can lower blood pressure and its propensity to cross the blood-brain barrier, Lexaria is investigating the potential for a positive outcome in the DEM-A22-1 study According to the World Health Organization (“WHO”), dementia is the seventh…

ThursdayDec 01, 2022 2:21 pm

QualityStocksNewsBreaks – Tingo Inc. (TMNA) Operating Business, Assets Acquisition by MICT Completed

Tingo (OTC: TMNA), a leading agri-fintech business in Africa, has been acquired by MICT Inc. (NASDAQ: MICT); the transaction was completed today. According to the announcement, the agreement includes 100% ownership of Tingo Inc.’s operating business and assets, specifically its subsidiary, Tingo Mobile Limited; 100% consolidation of Tingo Mobile’s revenues and income; 100% consolidation of Tingo Mobile’s balance sheet; and the opportunity to “globalize and dollarize an already established rapidly growing and highly scalable fintech and agri-fintech business.” The transaction included MICT issuing 19.9% of its common stock to Tingo, together with Series A Preferred Stock and Series B Preferred Stock, each of which are…

ThursdayDec 01, 2022 1:34 pm

QualityStocksNewsBreaks — MetAlert Inc. (MLRT) ‘Groundbreaking’ Tech for Senior Health Care Market Spotlighted in Recent Article

MetAlert (OTC: MLRT), a pioneer in the field of wearable GPS human and asset tracking and remote patient monitoring, is featured in a recent Market Herald article for its proprietary technologies, including RoomMate(TM). The article, which is titled “One Company Is Set to Pioneer Technologies for the Senior Health Care Market,” reports on RoomMate, MetAlert’s groundbreaking 3D fall detection and monitoring device. The 3D infrared fall-detection, automated monitoring system provides “anonymized” supervision and monitoring service using infrared 3D tech. The article noted that more than 5,500 devices are in operation in Norway, Sweden, Denmark and Iceland, and the company is…

ThursdayDec 01, 2022 12:35 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Closes on Acquisition of ELMS Plant, Assets and IP

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has officially closed on its previously announced acquisition of Electric Last Mile Solutions (“ELMS”) assets, including all IP and a factory located in Mishawaka, Indiana. The all-cash, $105 million transaction was completed on Nov. 30, 2022. According to the announcement, the ELMS acquisition allows Mullen to enter the commercial market much earlier than previously planned. In fact, the company plans to deliver class 1 product during the first quarter of 2023 and class 3 vehicles during the second quarter. The company noted that the factory, which previously produced General Motors’…

ThursdayDec 01, 2022 12:21 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys ASR Services for Five New Contracts, Unveils the ‘Rise of the Robots’

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced that it continues to accelerate market expansion with five new contracts for its Autonomous Security Robot (“ASR”) services in the health care market across multiple U.S. states. Describing deployment locations across a hospital group in Minnesota, an existing client in Ohio, a health care and rehabilitation center in New York, a hospital in Texas and health system in Louisiana, the announcement indicates that the wins underscore the need and desire to provide a safe environment for the nation’s health care workers and…

ThursdayDec 01, 2022 11:56 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Pricing for Public Offering

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced the pricing of a public offering. The offering is comprised of 1,889,764 shares of common stock (or prefunded warrants in lieu thereof) along with warrants to purchase up to 1,889,764 shares of common stock at a combined public offering price of $3.175 per share and associated warrant. The company noted that common warrants will be immediately exercisable at $3.03 per share and will expire five years following the initial exercise date. According to the announcement, the…

ThursdayDec 01, 2022 11:15 am

Reklaim Ltd.’s (TSX.V: MYID) (OTCQB: MYIDF) Q3 2022 Results Reveal 217% YoY Revenue Increase, 142% Gross Margin Growth

Reklaim posted Q3 2022 results showing 217% YoY revenue growth, 142% YoY gross margin increase, 90% year-to-date recurring revenue growth, and 28% more customers since year-end 2021 The online advertising industry depends heavily on consumer data, but government regulations and tech company restrictions are severely cutting supply Reklaim fills the void with an identity ecosystem that compensates users for consenting to share data while providing fully compliant data sets to marketers Reklaim (TSX.V: MYID) (OTCQB: MYIDF), the destination for consumers to access and reclaim their data, recently posted its financial results for the three months that ended September 30, 2022.…

Site Search

Company Search

Month: December 2022